Montelukast Prescribing at TOWER HOUSE PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,182
Total Quantity
37.3K
NHS Cost
£1.9K
vs National Avg
+72.6%
TOWER HOUSE PRACTICE prescribed 1,182 items of Montelukast over the last 12 months at a cost of £1,865 to the NHS. This is 72.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
104
Jun 2026
91
Jun 2026
102
Jun 2026
92
Jun 2026
86
Jun 2026
99
Jun 2026
102
Jun 2026
104
Jun 2026
115
Jun 2026
101
Jun 2026
92
Jun 2026
94
Prescribing Details
| Total Items | 1,182 |
|---|---|
| Total Quantity | 37,324 |
| Total NHS Cost | £1,865 |
| Presentations | 4 different forms |
| vs National Average | +72.6% |
Montelukast Prescribing Comparison
| This practice | 1,182 items |
|---|---|
| National average per practice | 685 items |
| Difference | +72.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.